CAS: 2070009-31-1
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | (R,S)-Ivosidenib REF: TM-T13438CAS: 2070009-31-1 | - - - | 63,00 €~88,00 € | Ter 03 Dez 24 |
 | (S)-N-((R)-1-(2-Chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopy rrolidine-2-carboxamide REF: 3D-VHD00931CAS: 2070009-31-1 | Min. 95% | A consultar | Qui 09 Jan 25 |
(R,S)-Ivosidenib
CAS:2070009-31-1
(R,S)-Ivosidenib is the less active enantiomer of Ivosidenib .
Fórmula:
C28H22ClF3N6O3
Cor e Forma:
Solid
Peso molecular:
582.96
Ref: TM-T13438
| 2mg | 88,00 € |
Entrega estimada em Estados Unidos, Terça-feira 3 de Dezembro de 2024
(S)-N-((R)-1-(2-Chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopy rrolidine-2-carboxamide
CAS:2070009-31-1
Please enquire for more information about (S)-N-((R)-1-(2-Chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopy rrolidine-2-carboxamide including the price, delivery time and more …
Fórmula:
C28H22ClF3N6O3
Pureza:
Min. 95%
Peso molecular:
583 g/mol
Ref: 3D-VHD00931
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 9 de Janeiro de 2025
